共 296 条
[1]
Svedbom A(2013)Osteoporosis in the European Union: a compendium of country-specific reports Arch Osteoporos 8 137-795
[2]
Hernlund E(2001)Osteoporosis prevention, diagnosis, and therapy JAMA 285 785-195
[3]
Ivergard M(2011)Femoral neck bone mineral density and 10-year absolute fracture risk in a national representative sample of Bulgarian women aged 50 years and older Arch Osteoporos 6 189-517
[4]
Compston J(2008)Loss of treatment benefit due to low compliance with bisphosphonate therapy Osteoporos Int 19 511-6
[5]
Cooper C(2013)Osteoporosis medication adherence: physician perceptions vs. patients’ utilization Bone 55 1-3259
[6]
Stenmark J(2013)Bisphosphonates adherence for treatment of osteoporosis Int Arch Med 6 24-1501
[7]
McCloskey EV(2010)The complex relation between bisphosphonate adherence and fracture reduction J Clin Endocrinol Metab 95 3251-928
[8]
Jonsson B(2007)Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis Mayo Clin Proc 82 1493-1022
[9]
Kanis JA(2006)Assessment of compliance with osteoporosis treatment and its consequences in a managed care population Bone 38 922-1429
[10]
EURPo IOF(2006)Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases Mayo Clin Proc 81 1013-765